Clinical Trial Update: Pilot Study on Evaluating the Geroprotective Effect of Metformin [Phase 2]

View source ↗

Summary

A Phase 2 pilot study at Xuanwu Hospital in Beijing is evaluating whether metformin has geroprotective effects for aging, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Metformin, Aging | Phase 2 | Status: RECRUITING